Skip to main content
. 2022 Dec 14;199(1):67–77. doi: 10.1007/s00066-022-02032-y

Fig. 2.

Fig. 2

Risk of any-grade radiation pneumonitis depending on administered adjuvant therapeutics and co-irradiation of the lung. The odds of developing any-grade RP of each treatment subgroup in reference to all other treatments are displayed. The relative risk for RP development depending on MLD was referenced to patients exposed to less than 5 Gy MLD each